Page 9 - Nyse Path News Today

Sonnipe Ltd bought a new position in shares of UiPath Inc. (NYSE:PATH – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,008 shares of the healthcare company’s stock, valued at approximately $26,000. Other hedge funds have also modified their […]

180 Wealth Advisors LLC boosted its stake in UiPath Inc. (NYSE:PATH – Get Rating) by 2.0% in the 4th quarter, Holdings Channel reports. The firm owned 149,229 shares of the healthcare company’s stock after purchasing an additional 2,870 shares during the period. 180 Wealth Advisors LLC’s holdings in UiPath were worth $2,173,000 at the end […]

UiPath (NYSE:PATH – Get Rating) and Cellebrite DI (NASDAQ:CLBT – Get Rating) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability. Valuation and Earnings This table compares UiPath and Cellebrite DI’s […]

Sumitomo Mitsui Trust Holdings Inc. decreased its holdings in UiPath Inc. (NYSE:PATH – Get Rating) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,293,681 shares of the healthcare company’s stock after selling 1,899,365 shares during the period. Sumitomo Mitsui […]

UiPath Inc. (NYSE:PATH – Get Rating) shares gapped down before the market opened on Monday . The stock had previously closed at $16.55, but opened at $16.19. UiPath shares last traded at $16.32, with a volume of 1,243,563 shares traded. Analyst Ratings Changes A number of analysts have commented on PATH shares. TD Cowen increased […]

Shares of UiPath Inc. (NYSE:PATH – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the nineteen research firms that are presently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average […]

Shares of UiPath Inc. (NYSE:PATH – Get Rating) have earned an average rating of “Moderate Buy” from the nineteen brokerages that are covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among […]

UiPath (NYSE:PATH – Get Rating) had its price target increased by Royal Bank of Canada from $17.00 to $18.00 in a report released on Wednesday, The Fly reports. They currently have a sector perform rating on the healthcare company’s stock. Several other equities analysts have also recently issued reports on the stock. Truist Financial dropped […]

UiPath (NYSE:PATH – Get Rating) had its price target hoisted by Royal Bank of Canada from $17.00 to $18.00 in a research note published on Wednesday, The Fly reports. They currently have a sector perform rating on the healthcare company’s stock. A number of other analysts have also recently commented on PATH. Credit Suisse Group […]

Bank of New York Mellon Corp grew its holdings in shares of UiPath Inc. (NYSE:PATH – Get Rating) by 22.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,801,779 shares of the healthcare company’s stock after buying an additional 329,651 shares during the period. Bank […]